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Skeletal muscle contractility is important for locomotion and 
posture, activities performed by different myofiber types with dis-
tinct contractile and metabolic properties. Mitochondria serve a cru-
cial function in the maintenance of skeletal myofiber homeostasis 
and matching energy production with demand. They do so through 
oxidation of glucose-derived pyruvate and β-oxidation of fatty 
acids, generating an electrochemical proton gradient through 
the respiratory complexes of the electron transport chain; this gra-
dient can be used to drive the phosphorylation of ADP to ATP, 
a reaction called oxidative phosphorylation (OXPHOS). However, 
what determines mitochondrial content and function is not com-
pletely understood.
Nuclear receptors and their cofactors regulate metabolism in 
response to environmental signals and trigger homeostatic responses 
by coordinately regulating transcriptional networks. Previous studies 
have established that nuclear receptors, such as peroxisome 
 proliferator-activated receptor-β/δ (Ppar-β/δ), estrogen-related 
receptor-α and estrogen-related receptor-γ, along with co-regulators 
such as Ppar-γ coactivator-1α (Ppargc-1α) and Ppargc-1β, as well as 
nuclear receptor co-repressor 1 (Ncor1), among others, control muscle 
physiology by modulating mitochondrial biogenesis and function, 
fiber type determination and switching and muscle vascularization1–5. 
Ppargc-1α is a master driver of mitochondrial biogenesis, and its 
overexpression in skeletal muscle results in increased mitochondrial 
number and function1, whereas skeletal muscle Ppargc-1α deficiency 
leads to a reduced number of mitochondria and a marked reduction 
of muscle oxidative capacity6,7.
The nuclear receptor Rev-erb-α is expressed in tissues such as 
liver and adipose tissue8, where it modulates lipid, bile acid and 
glucose metabolism8–13. In addition, Rev-erb-α controls adipogen-
esis14,15 and the macrophage inflammatory response16. Rev-erb-α 
interacts with Ncor1 and chromatin modifiers, such as histone 
deacetylase 3, to form a complex repressing target gene transcrip-
tion17. Notably, a Rev-erb-α–Ppargc-1α cross-talk pathway regulates 
heme synthesis in hepatic cells18,19. Whether Rev-erb-α interacts 
with Ppargc-1α in muscle and whether Rev-erb-α controls skel-
etal muscle oxidative capacity has not yet been investigated. Here 
we find through loss- and gain-of-function experiments, includ-
ing pharmacological activation, that Rev-erb-α plays a key role 
in regulating the oxidative capacity of the muscle and exercise 
endurance, and thus it emerges as a potential target to improve 
muscle function.
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Rev-erb-α modulates skeletal muscle oxidative capacity 
by regulating mitochondrial biogenesis and autophagy
Estelle Woldt1–5,9, Yasmine Sebti1–5,9, Laura A Solt6, Christian Duhem1–5, Steve Lancel4,7, Jérôme Eeckhoute1–5, 
Matthijs K C Hesselink8, Charlotte Paquet1–5, Stéphane Delhaye1–5, Youseung Shin6, Theodore M Kamenecka6, 
Gert Schaart8, Philippe Lefebvre1–5, Rémi Nevière4,7, Thomas P Burris6, Patrick Schrauwen8, Bart Staels1–5 & 
Hélène Duez1–5
The nuclear receptor Rev-erb-a modulates hepatic lipid and glucose metabolism, adipogenesis and the inflammatory response 
in macrophages. We show here that Rev-erb-a is highly expressed in oxidative skeletal muscle and that its deficiency in muscle 
leads to reduced mitochondrial content and oxidative function, as well as upregulation of autophagy. These cellular effects 
resulted in both impaired mitochondrial biogenesis and increased clearance of this organelle, leading to compromised exercise 
capacity. On a molecular level, Rev-erb-a deficiency resulted in deactivation of the Lkb1-Ampk-Sirt1–Ppargc-1a signaling 
pathway. These effects were recapitulated in isolated fibers and in muscle cells after knockdown of the gene encoding Rev-erb-a, 
Nr1d1. In complementary experiments, Rev-erb-a overexpression in vitro increased the number of mitochondria and improved 
respiratory capacity, whereas muscle overexpression or pharmacological activation of Rev-erb-a in vivo increased exercise 
capacity. This study identifies Rev-erb-a as a pharmacological target that improves muscle oxidative function by modulating gene 
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RESULTS
Nr1d1−/− mice have lower exercise capacity
Rev-erb-α expression is markedly higher in oxidative compared to more 
glycolytic muscles (Fig. 1a). Notably, its expression is higher in soleus 
and gastrocnemius muscle upon exercise training (Supplementary 
Fig. 1a). Thus, we explored whether Rev-erb-α has a role in skeletal 
muscle oxidative capacity and exercise capacity. Nr1d1−/− mice showed 
significantly less spontaneous locomotor activity in a free-wheel exer-
cise regimen compared to wild-type (WT) littermates (Fig. 1b).
We next assessed basal (VO2b) and maximal (VO2max) oxygen 
consumption, which reflect aerobic capacity, by submitting Nr1d1−/− 
and WT mice to a forced progressive treadmill exercise. VO2b mea-
sured at rest was not significantly different between the two geno-
types, whereas VO2max measured at exhaustion was significantly 
lower in Nr1d1−/− mice (Fig. 1c), resulting in a >60% reduction in 
aerobic capacity during exercise. In a standard endurance exercise 
test performed at 70% of their respective VO2max, 50% of Nr1d1−/− 
mice, compared to only 20% of the WT mice, stopped running within 
50 min, which indicates their inability to sustain a long-lasting exer-
cise (Fig. 1d). In this setting, Nr1d1−/− mice ran for a significantly 
shorter time and distance than their WT littermates (Fig. 1e,f).
Rev-erb-a controls muscle mitochondrial content and function
We assessed the role of Rev-erb-α in the control of mitochondrial 
number and function in vivo (Fig. 2). Mitochondrial DNA content 
was ~40% lower in skeletal muscle from Nr1d1−/− mice compared 
to WT littermates (Fig. 2a), suggesting that Rev-erb-α is involved 
in regulating skeletal muscle mitochondrial content. Accordingly, 
expression of genes encoding subunits of the mitochondrial elec-
tron transport respiratory chain, such as NADH dehydrogenase 1, 
a subunit of complex I, and cytochrome c oxidase 1 and cytochrome 
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Figure 1 Nr1d1−/− mice have reduced voluntary activity and exercise performance. (a) Western blot analysis of Rev-erb-α protein levels in mouse 
muscles; actin was used as control. Qua, quadriceps; Sol, soleus; Gas, gastrocnemius; EDL, extensor digitorum longus; Dia, diaphragm; TA, tibialis 
anterior (n = 7 per group). (b) Wheel voluntary activity of Nr1d1−/− mice compared to WT mice (n = 5 per genotype). (c) Basal (at rest) and maximal 
aerobic capacity (VO2) during a progressive treadmill test to exhaustion in an enclosed single-lane treadmill (n = 9 or 10 per genotype). (d) Endurance 
capacity of Nr1d1−/− mice compared to WT mice (n = 6 per genotype). (e,f) Running time (e) and distance (f) until exhaustion in endurance exercise  











































































































































































































































































Figure 2 Rev-erb-α modulates mitochondrial content and function. (a) Mitochondrial DNA (mtDNA) content (n = 6 per genotype). Mt-Nd1, the gene 
encoding mitochondrial NADH dehydrogenase 1. (b) RT-qPCR analysis of mitochondrial respiratory chain subunit genes in soleus muscle (n = 7 per 
genotype). Mt-Co1, mitochondrial cytochrome c oxidase 2 gene; Mt-Co2, mitochondrial cytochrome c oxidase 2 gene. (c) Western blot analysis of 
mitochondrial complexes in soleus muscle from Nr1d1−/− and WT mice (n = 4 or 5 per genotype). (d) Mitochondrial respiration in permeabilized soleus 
muscle fiber from Nr1d1−/− and WT mice (n = 7 per genotype). Succ, succinate; Rot, rotenone. (e) Mitochondrial respiration from isolated muscle 
mitochondria (n = 5 per genotype). (f) Mitochondrial fatty acid β-oxidation–dependent respiration in isolated permeabilized soleus muscle fibers  
from Nr1d1−/− and WT mice (n = 6 per genotype). (g) Skeletal muscle (soleus) expression of genes encoding proteins involved in fatty acid oxidation 
(n = 7 per genotype). (h) Electron microscopy analysis of muscle from Nr1d1−/− and WT mice. Black arrows, swollen, less dense mitochondria; white 
arrowheads, normal mitochondria. Representative images from n = 5 mice per genotype. Scale bar, 1 µm. Black, Nr1d1−/− mice; light gray, WT mice. 
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phosphorylation, as illustrated by higher-state 3u respiration rate and 
respiratory control ratio (RCR, OXPHOS/leak), whereas the uncou-
pling proton leakage remained unchanged (Fig. 3c). Conversely, 
Nr1d1 silencing resulted in lower mitochondrial respiration compared 
to control shRNA–infected cells (Supplementary Fig. 2a), as well as 
the quantity of total (MitoTracker Green) and functional (MitoTracker 
Red) mitochondria (Supplementary Fig. 2b) in differentiated C2C12 
cells. Analysis of mitochondrial fatty acid oxidation in permeabilized 
fibers of muscle from Nr1d1−/− mice revealed compromised oxygen 
consumption in the presence of palmitoyl-l-carnitine plus malate 
alone and in the presence of ADP (Fig. 2f). In parallel, the expression 
of genes encoding enzymes of fatty acid β-oxidation, notably carnitine 
palmitoyltransferase 1B (Cpt1b) and (very) long chain (Acadvl and 
Acadl) and short chain (Acads) acyl-CoA dehydrogenases, was lower 
in skeletal muscle from Nr1d1−/− compared with WT mice (Fig. 2g and 
Supplementary Fig. 3a), whereas REV-ERB-α retrovirus–infected 
C2C12 cells had a mirror phenotype (that is, higher Acadvl, Acadl and 
Acads expression, and thus a higher acyl-CoA dehydrogenase expres-
sion) compared to control cells infected with an empty control pBabe 
retrovirus (Fig. 3d). These results indicate that Rev-erb-α modulates 
fatty acid β-oxidation–driven generation of reducing equivalents to 
feed into the electron transport chain in vitro and ex vivo in skeletal 
muscle. Together, these results demonstrate that Rev-erb-α regulates 
muscle cell mitochondrial content and function.
Electron microscopy analysis of muscle sections revealed a slight 
misalignment of Z lines, the presence of vacuolated fibers and the 
presence of abnormal, swollen and less dense mitochondria in muscle 
sections from Nr1d1−/− mice compared to WT littermates (Fig. 2h  
and Supplementary Fig. 4), which indicate a severe skeletal mus-
cle phenotype and mitochondrial dysfunction in the Nr1d1−/− 
mice. The repair process, assessed by the presence of centrocellular 
nuclei (Supplementary Fig. 5a shows that the nuclei are localized 
at the periphery of the fibers, confirming the absence of regenera-
tion) and the absence of change in the expression of Pax7 and Myf5 
(Supplementary Fig. 5b), was not different between Nr1d1−/− mice 
and WT littermates. In line with this, immunofluorescence staining 
of Pax7 indicated its localization at the boundary of the myofiber 















































































































































































Figure 3 Rev-erb-α modulates mitochondrial respiration. (a) Mitochondria content in C2C12 cells infected with REV-ERB  
or control (pBabe) retrovirus by flow cytometry analysis of MitoTracker (MT) Green staining (left, representative histogram; 
right, mean fluorescence intensity (MFI)) (n = 6 per condition). (b) Functional mitochondria content by flow cytometry 
analysis of JC-1 (left and middle) and red/green JC-1 (the high-low mitochondrial membrane potential) MFI ratio (right)  
(n = 6 per condition). (c) Oxygen consumption in REV-ERB-α and control pBabe cells (n = 5 per condition). (d) RT-qPCR 
analysis of fatty acid oxidation gene expression in differentiated C2C12 cells infected with REV-ERB-α or control (pBabe) 
retrovirus (n = 6 per group). Data are expressed as means ± s.e.m. *P < 0.05, ***P < 0.001 by unpaired t-test.
 quadriceps muscle from Nr1d1−/− mice compared to WT mice (Fig. 2b  
and Supplementary Fig. 1b). In addition, relative protein amounts 
of the mitochondrial oxidative phosphorylation complexes were 
lower in muscle from Nr1d1−/− mice compared to WT mice (Fig. 2c 
and Supplementary Fig. 1c). Moreover, glutamate-malate–stimulated 
(state 2) respiration was lower in isolated fibers from Nr1d1−/− mice 
compared to WT mice, in line with the reduced mitochondrial 
content (Fig. 2d). Mitochondrial oxidative capacity was impaired 
in muscle from Nr1d1−/− mice, as attested by a significantly lower 
ADP-driven glutamate-malate (state 3) respiration rate in saponin-
permeabilized fibers isolated from Nr1d1−/− compared to WT mice 
(Fig. 2d). The lower respiration upon addition of succinate and roten-
one demonstrates a reduced capacity of the entire chain rather than a 
deficiency in a specific complex. This was further underscored by the 
significantly lower respiration rate observed when comparing equal 
amounts of isolated mitochondria (Fig. 2e), illustrating not only less 
mitochondrial content but also lower respiratory chain function of 
isolated mitochondria from Nr1d1−/− compared to WT mice.
Although gene expression analysis of fiber type markers suggested 
a switch toward a more glycolytic profile (expression of the genes 
encoding tropomyosin 3, a marker of oxidative type I fiber, and 
myosin heavy chain IIa and IIx, markers of mostly oxidative fibers, 
is lower in soleus and quadriceps muscle from Nr1d1−/− mice com-
pared to WT mice (data not shown)), specific type I, type IIa and 
type IIb immunostaining did not reveal any significant changes 
between the two genotypes (Supplementary Fig. 1d). In addition, 
expression of Mb (the gene encoding myoglobin) and vascularization, 
assessed by CD31 immunostaining on soleus muscle sections, was 
similar between the two genotypes (Supplementary Fig. 5d,e).
To study whether Rev-erb-α regulates mitochondrial function in a 
cell-autonomous manner, we stably infected C2C12 muscle cells with 
a REV-ERB-α–coding retrovirus. Staining with MitoTracker Green, 
a marker of mitochondria content, was higher in cells overexpress-
ing REV-ERB-α compared with those infected with a control vector 
(Fig. 3a). Notably, the red-to-green ratio of JC-1 fluorochrome, an 
indicator of membrane potential, was also higher in C2C12 cells 
overexpressing REV-ERB-α compared to cells infected with an 
empty pBabe control retrovirus, suggesting increased mitochondrial 
activity (Fig. 3b). REV-ERB-α expression enhanced the maximal res-
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satellite cells located on the border of myofibers, which are similar 
in the two genotypes.
Rev-erb-a increases skeletal muscle mitochondrial biogenesis
We assessed whether Rev-erb-α regulates mitochondrial biogenesis 
in  loss- and gain-of-function settings (Fig. 4). Both mRNA (~56%) 
and protein (~50%) amounts of Ppargc-1α, which has a pivotal role 
in mitochondrial biogenesis, were lower in soleus and quadriceps 
muscle from Nr1d1−/− mice as compared to WT mice (Fig. 4a and 
Supplementary Fig. 3b,d). Consistently, the expression of Tfam and 
Nrf1, encoding mitochondrial transcription factor A and nuclear 
respiratory factor 1, respectively, two transcription factors that are 
involved in mitochondrial biogenesis, was lower in Nr1d1−/− mice 
compared to WT mice (Fig. 4b). By contrast, REV-ERB-α over-
expression resulted in higher Ppargc1a and Tfam expression in 
C2C12 cells compared to cells infected with an empty pBabe control 
retrovirus (Fig. 4h).
As a functional reflection of impaired mitochondrial electron trans-
port chain activity, ATP concentrations were significantly lower in 
muscle from Nr1d1−/− mice compared to WT mice (Fig. 4c). Ampk, 
a ‘fuel gauge’ activated by liver kinase B1 (Lkb1, also known as serine-
 threonine kinase 11 or Stk11) when the AMP/ATP ratio increases, 
induces Sirt1-dependent deacetylation of Ppargc-1α and expression 
of nicotinamide phosphoribosyltransferase (Nampt), the rate-limiting 
enzyme in the synthesis of the Sirt1 cofactor NAD+, thus affecting mito-
chondrial and lipid oxidation genes20. Of note, Stk11 gene expression 
(Fig. 4d and Supplementary Fig. 3d), Ampk phosphorylation (Fig. 4e) 
and activity illustrated by the p-Acac/Acac (phosphorylated acetyl-
CoA carboxylase/total acetyl-CoA carboxylase) ratio (Supplementary 
Fig. 3c) and Nampt gene expression (Fig. 4f) were lower in muscle 
from Nr1d1−/− mice compared to WT mice. Concentrations of NAD+ 
and NADH, the reducing equivalent produced by fatty acid oxida-
tion, were lower in skeletal muscle from Nr1d1−/− mice compared to 
that of their WT littermates (Fig. 4f). Moreover, we observed signifi-
cantly less Sirt1 expression in skeletal muscle from Nr1d1−/− com-
pared to WT mice (Fig. 4f and Supplementary Fig. 3d), and SIRT1 
activity was blunted, as attested by increased Ppargc-1α acetylation 
(Fig. 4g). Conversely, Sirt1 and Nampt expression was induced in 
REV-ERB-α–overexpressing C2C12 cells (Fig. 4h) and accompanied 
by significantly improved mitochondrial respiration, an effect that was 
fully blocked by the addition of the C compound, an inhibitor of Ampk 
phosphorylation (Fig. 4i). Consistent with this, siRNA knockdown of 
genes encoding Ampk (Prkaa1 and Prkaa2) prevented the increase 
in mitochondrial content upon REV-ERB-α overexpression (Fig. 4j), 
whereas Ampk activation by 5-aminoimidazole-4-carboxamide 
ribonucleotide (AICAR) increased mitochondrial number in cells 
stably transduced with Nr1d1 shRNA but not to the same extent as in 
control cells stably transduced with control shRNA (Supplementary 
Fig. 2c). Together, these data indicate that Rev-erb-α regulates 
skeletal muscle mitochondria biogenesis through modulation of the 
Lkb1-Ampk-Sirt1–Ppargc-1α pathway.
Rev-erb-a deficiency induces skeletal muscle autophagy
We next explored whether Rev-erb-α also modulates mitochondrial 
degradation. Autophagy is a process mediating the selective clear-
ance of cytoplasmic components, such as damaged mitochondria, that 
could otherwise become deleterious. Autophagy is a self-digestion 
process occurring through the formation of a vesicle (nucleation) 
that expands to become an autophagosome, which then engulfs cel-
lular components and directs them to the lysosome for degradation. 
Expression of the genes encoding Ulk1, a protein of the initiation 






























































































































































































































































































































Figure 4 Rev-erb-α modulates mitochondrial biogenesis by interfering  
with Ampk–Sirt1–Ppargc-1α signaling. (a–g) Relative protein amounts  
of Ppargc-1α (a), mRNA concentrations of Tfam and nuclear respiratory  
factor 1 (Nrf1) (b), cellular ATP concentrations (c), Stk11 mRNA  
concentrations (d), western blot analysis of Ampk phosphorylation (e),  
Nampt and Sirt1 mRNA and NAD+ and NADH cellular concentrations (f) and  
relative amounts of acetylated Ppargc-1α protein (g) in soleus muscle from  
Nr1d1−/− and WT mice (n = 7 per genotype). Black, Nr1d1−/− mice; light gray, WT mice (a–g). IB, immunoblot. (h) Ppargc1a, Tfam, Sirt1 and Nampt 
gene expression in C2C12 cells infected with REV-ERB-α or control (pBabe) retrovirus (n = 6 per group). Light gray, empty pBabe retrovirus–infected 
cells; dark gray, REV-ERB-α–overexpressing cells (h–j). (i) OXPHOS (3u) mitochondrial respiration and RCR in absence or presence of the Ampk 
phosphorylation inhibitor C compound (CC) in C2C12 cells infected with REV-ERB-α or control (pBabe) retrovirus (n = 6 per condition). (j) Mitochondria 
content in C2C12 cells infected with REV-ERB-α or control (pBabe) retrovirus, transfected with siRNA to reduce Prkaa1 and Prkaa2 expression or a 
scramble control siRNA/MitoTracker Green MFI (n = 3 per condition). Results are expressed as means ± s.e.m. *P < 0.05, **P < 0.01, and ***P < 0.001, 
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the nucleation complex, as well as autophagy-related 5 (Atg5) and 
Bnip3, which are responsible for vesicle elongation and autophago-
some formation, and the lysosomal enzymes cathepsin L (Ctsl) and 
ATPase6v1b2 was higher in skeletal muscle of Nr1d1−/− compared to 
WT mice (Fig. 5a,b) and lower in REV-ERB-α retrovirus–infected 
C2C12 cells compared to control cells infected with an empty pBabe 
control retrovirus (Supplementary Fig. 6). Rev-erb-α also regulated 
gene and protein expression of Parkin (also known as Park2), a pro-
tein specifically involved in mitochondrial clearance21 (Fig. 5b and 
Supplementary Fig. 6). The functional increase of autophagy was 
illustrated by the maturation of microtubule-associated protein 1 
light chain 3α (Map1lc3a-I, also known as LC3) to its lipidated form, 
Map1lc3a-II, a marker of ongoing autophagy associated with the 
autophagosome membrane (Fig. 5c). Moreover, treatment with the 
lysosome inhibitors bafilomycin and NH4Cl, which block the fusion 
of the lysosome with mature autophagosomes that subsequently 
accumulate, resulted in a smaller increase of Map1lc3a-II expression 
in REV-ERB-α–overexpressing C2C12 cells than in treated control 
(pBabe) cells (Fig. 5d). This indicates that autophagy flux is lower 
when REV-ERB-α is overexpressed. Conversely, the number of mito-
chondria was lower after Nr1d1 silencing in C2C12 cells, and addition 
of the autophagy blockers 3-methyl adenine and chloroquine or the 
lysosome inhibitors bafilomycin and NH4Cl prevented this decrease 
(Fig. 5e). These results suggest that Rev-erb-α deficiency results 
in an increased autophagy flux, thus contributing to the lower 
mitochondria number.
To gain further mechanistic insight, we examined the distribu-
tion of Rev-erb-α binding sites in the vicinity of autophagy genes, 
assessed using chromatin immunoprecipitation (ChIP) sequencing 
data17, and overlaid it with epigenetic marks obtained in C2C12 
myotubes22. We reasoned that intense transcriptional activity at 
these marks may increase the likelihood of Rev-erb-α binding 
to these locations. Primers for ChIP–quantitative PCR (qPCR) target-
ing these regions were then designed to assess REV-ERB-α binding 
and changes in acetylation marks in REV-ERB-α–expressing C2C12 
cells. We observed an enrichment of Rev-erb-α binding in the regula-
tory regions of several autophagy genes (Fig. 5f), which was associated 
with decreased acetylation at histone 3 Lys27 (H3K27) (Fig. 5g) and 
Lys9 (H3K9) (Fig. 5h).
Rev-erb-a activation improves muscle mitochondrial function
Next, we determined the effect of pharmacological activation of 
Rev-erb-α on exercise capacity, which we achieved by treating mice 
with the synthetic ligand SR9009 (ref. 12). Notably, in an endurance 
exercise test, mice treated with SR9009 ran significantly longer, both 
in time and in distance, than mice treated with vehicle (Fig. 6a).
Incubation of C2C12 cells with two different Rev-erb agonists, 
SR9009 and SR9011, increased the number of total (MitoTracker 
Green) and active (MitoTracker Red) mitochondria (Fig. 6b). 
Finally, skeletal muscle–specific Rev-erb-α overexpression in mice 
significantly improved mitochondrial function, as attested by a sig-





















































































































































































































































































































Figure 5 Rev-erb-α modulates skeletal muscle autophagy. (a) RT-qPCR analysis of autophagy gene expression  
in soleus from Nr1d1−/− and WT littermates (n = 7 per genotype). (b) Western blot analysis and their  
quantifications of soleus muscle Park2 and Bnip3 proteins in Nr1d1−/− mice compared to WT littermates.  
(c) Western blot analysis and their quantifications of Map1lc3a-I and Map1lc3a-II protein in soleus from  
Nr1d1−/− and WT mice (n = 3 or 4 per genotype). (d) Flow cytometry quantification of Map1lc3a-II  
protein amounts in C2C12 cells infected with REV-ERB-α or control (pBabe) retrovirus and treated with  
lysosome inhibitors (50 nM bafilomycin or 25 mM NH4Cl) or their respective vehicle after 16 h serum  
deprivation, expressed as MFI (lysosomal inhibitors minus vehicle) (n = 6 per condition). (e) Mitochondria  
content in cells that have been stably transduced using an Nr1d1 shRNA–encoding retrovirus or control (CTL) shRNA  
and treated with 5 mM 3-methyl adenine (3-MA) or 50 µM chloroquine (CQ), or 100 nM bafilomycin or 25 mM NH4Cl, or their respective vehicle, as 
measured by specific MitoTracker (MT) Green flow cytometry MFI (n = 6 per condition). (f) Rev-erb-α binding to regulatory regions of the indicated 
autophagy genes measured by ChIP-qPCR (n = 3 independent experiments). (g,h) ChIP-qPCR examining the REV-ERB-α binding regions from e for 
changes in H3K27 and H3K9 acetylation (n = 3 independent experiments). (f–h) ChIP experiments were conducted on C2C12 cells infected with  




























a r t i c l e s
1044  VOLUME 19 | NUMBER 8 | AUGUST 2013 nature medicine
respiration in the absence and presence of succinate in permeabi-
lized fibers (Fig. 6c). Together, these data indicate that enhancement 
of Rev-erb-α expression, activity or both exerts beneficial direct 
effects on skeletal muscle to improve mitochondrial respiration and 
exercise capacity.
DISCUSSION
Our results from both gain- and loss-of-function experiments iden-
tify Rev-erb-α as a physiological regulator of muscle mitochondrial 
content and oxidative function. This is supported by several obser-
vations. First, Rev-erb-α is preferentially expressed in more oxida-
tive muscles, such as soleus muscle, and Nr1d1−/− mice have notably 
altered exercise capacity associated with a marked decrease in mito-
chondrial content and function, the presence of swollen mitochondria 
and abundant vacuoles within the fibers. We observed similar altera-
tions upon knockdown of Nr1d1 in differentiated C2C12 myotubes 
(lower mitochondrial content and impaired mitochondrial function). 
By contrast, pharmacological activation or skeletal muscle–specific 
Rev-erb-α overexpression in vivo and in vitro in C2C12 cells resulted 
in the opposite phenotype, highlighting the fact that Rev-erb-α exerts 
a direct action on skeletal muscle cells. Second, our data indicate that 
Rev-erb-α controls mitochondrial biogenesis and respiration through 
the Lkb1-Ampk-Sirt1–Ppargc-1α signaling pathway. Finally, we show 
that skeletal muscle Rev-erb-α regulates several genes involved in 
different steps of the autophagy process, including genes more specifi-
cally dedicated to mitophagy. Together, these data support the concept 
that Rev-erb-α acts through a two-pronged mechanism, involving 
both biogenesis of new mitochondria and clearance of defective mito-
chondria. Thus, when Rev-erb-α is activated, there is an increase in 
mitochondrial number and a better control of autophagic flux, allow-
ing for a higher oxidative capacity.
The regulation of the Lkb1-Ampk-Sirt1–Ppargc-1α pathway by 
Rev-erb-α provides a molecular mechanism whereby Rev-erb-α 
controls mitochondrial biogenesis and function. Ampk and Sirt1 
are crucial in the metabolic flexibility that allows skeletal muscle to 
switch to lipid oxidation during fasting and exercise. Deficient Ampk 
activity in Nr1d1−/− mice is associated with impaired Sirt1-mediated 
Ppargc-1α deacetylation and the ensuing attenuated induction of 
mitochondrial fatty acid oxidation gene expression and reduced 
exercise capacity20,23. Likewise, Ppargc-1α acetylation is higher and 
its expression diminishes in Rev-erb-α deficiency, which may con-
tribute to the reduced number of mitochondria, lower expression 
of transcription factors important for mitochondrial function, such 
as Tfam, and altered electron transport chain activity. In addition, 
expression of genes encoding fatty acid β-oxidation enzymes as well as 
palmitate-induced mitochondrial respiration is compromised in the 
absence of Rev-erb-α. A considerable deactivation of the Lkb1-Ampk-
Sirt1-Ppargc-1α pathway when Rev-erb-α is deficient is further 
shown by defective Ampk activation, reduced NAD+ concentrations 
and markedly altered Sirt1 and Nampt expression. Moreover, siRNA-
mediated or C compound–mediated inhibition of Ampk activity, 
which blocks the stimulatory effect of REV-ERB-α overexpression 
on mitochondrial respiration, demonstrates that Rev-erb-α–mediated 
improvement of mitochondrial respiration requires active Ampk. 
Of note, in Nr1d1−/− mice, Ampk phosphorylation is not induced 
even though ATP concentrations are low. Binding of AMP increases 
the ability of other kinases to phosphorylate and activate the Ampk-α 
subunit. Lkb1, expressed in skeletal muscle, is a major upstream kinase 
that phosphorylates and activates Ampk, and Stk11-deficiency results 
in blunted Ampk activation, decreased Ppargc1a expression, reduced 
exercise capacity and compromised mitochondrial activity24,25, a phe-
notype similar to the one observed in the Nr1d1−/− mice. Our results 
also indicate that mitochondria are damaged and mitochondrial 
oxygen consumption is reduced in muscle from Nr1d1−/− mice, 
whereas skeletal muscle-specific Rev-erb-α overexpression improves 
mitochondrial respiration. Moreover, treatment of mice with a syn-
thetic Rev-erb-α agonist increases oxygen consumption12. Notably, 
and in contrast to other transcriptional regulators, such as Ppar-β/δ 
(ref. 2) and Ppargc-1α (refs. 1,6), Rev-erb-α modulates skeletal muscle 
oxidative capacity without inducing a fiber type switch, suggesting 
a disconnection between both phenomena upon Rev-erb-α defi-
ciency. Together, these data support a prominent role for Rev-erb-α in 
skeletal muscle mitochondria function.
Autophagy is a dynamic self-digestion process that ensures the 
selective clearance of damaged organelles or aggregated macromol-
ecules, which is a particularly important mechanism in differentiated 
cells such as myotubes26–28. Our data demonstrate that Rev-erb-α 
exerts a tight control on this pathway by regulating several genes 
involved in vesicle nucleation and expansion, autophagosome forma-
tion and lysosomal enzymatic activities. The conversion of Map1lc3a-I 
to its lipidated form, Map1lc3a-II, is a hallmark of autophagy29. 
The rate of maturation to Map1lc3a-II was elevated in the absence 
of Rev-erb-α, whereas autophagy flux is decreased by REV-ERBα 
overexpression. Of note, Rev-erb-α represses genes encoding proteins 
that trigger mitophagy, such as Park2, a cytosolic E3 ubiquitin ligase 
that translocates to depolarized mitochondria to induce mitophagy, 
thereby maintaining a pool of functioning mitochondria and limiting 
oxidative damage21. Likewise, Rev-erb-α downregulates Ulk1, which 
not only participates in the initiation complex but also may play an 
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Figure 6 Rev-erb-α overexpression or pharmacological 
activity improves mitochondrial function and exercise 
capacity. (a) Running distance and time until 
exhaustion in endurance exercise in mice treated with 
SR9009 (100 mg per kg body weight for 30 d) (n = 6 
per group). (b) Mitochondria content in C2C12 
cells treated with SR9009 (5 µM), SR9011 (5 µM) 
or vehicle as shown by representative bar graph 
of flow cytometry green MitoTracker (top) and red 
MitoTracker (bottom) staining (n = 4 per condition). 
(c) Mitochondrial respiration in permeabilized fiber 
isolated from tibialis anterior muscle from mice 
intramuscularly injected with a Rev-erb-α–expressing 
adeno-associated virus (AAV) vector (AAV–Rev-erb-α) 
(n = 4 per group). Data are expressed as means ± 
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results in accumulation of defective mitochondria in mature red blood 
cells31. Finally, we demonstrate that autophagy blockade by autophagy 
or lysosome inhibitors reverses the effect of Nr1d1 knockdown on 
total mitochondria number.
Autophagy is also a survival mechanism by which cells produce 
energy in times of nutrient paucity. One of the most potent induc-
ers of autophagy is Ampk, which directly phosphorylates Ulk1 and, 
simultaneously, turns off signaling of mTORC1, an inhibitor of 
autophagy26,28,32. However, neither Ampk (which is downregulated in 
the absence of Rev-erb-α) nor mTOR, whose signaling is not regulated 
by Rev-erb-α (data not shown), is likely to mediate Rev-erb-α’s action 
on autophagy. Another potent autophagy inducer, Sirt1 (ref. 33), 
is also downregulated in the absence of Rev-erb-α, again 
excluding the possibility that Sirt1 has a role in the observed pheno-
type. Together, these data indicate that Rev-erb-α bypasses these regu-
lators and represses autophagy genes directly, probably by binding 
the DNA in their regulatory regions. Indeed, our ChIP-qPCR data 
confirmed Rev-erb-α binding enrichment in the regulatory regions 
of autophagy genes. This was accompanied by a modification of epige-
netic marks at these sites, as indicated by decreased H3K27 and H3K9 
acetylation, which is consistent with the repressive role of Rev-erb-α 
on gene transcription.
Rev-erb-α is a component of the circadian clock, which allows 
synchronization of internal rhythms to daily environmental cues34. 
Skeletal muscle has circadian rhythmicity of gene expression35,36, and 
the clock components Clock and Bmal1 (brain and muscle Arnt-like 1) 
have been shown to participate in the maintenance of skeletal muscle 
function37. The mRNA concentrations of the clock genes are altered 
in skeletal muscle from Nr1d1−/− mice (Supplementary Fig. 7a), and 
REV-ERB-α overexpression in synchronized C2C12 cells leads to an 
altered circadian expression pattern of Ppargc1a (Supplementary 
Fig. 7b). Pharmacological activation of Rev-erb-α alters the circadian 
rhythms of Cpt1b and Ppargc1a in skeletal muscle12. Consequently, 
in addition to the direct action of Rev-erb-α on autophagy genes and 
mitochondrial biogenesis and function, Nr1d1 deletion or overexpres-
sion that causes disturbed circadian rhythmicity may contribute to the 
observed phenotype. In conclusion, Rev-erb-α is a major physiological 
regulator of mitochondrial content and oxidative function. Thus, 
pharmacological activation of Rev-erb-α may be a promising approach 
for the treatment of skeletal muscle diseases with compromised 
exercise capacity.
METhODS
Methods and any associated references are available in the online 
version of the paper.
Note: Supplementary information is available in the online version of the paper.
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Mice. We used Nr1d1−/− mice38 and their wild-type (WT) littermates (Nr1d1+/+ 
mice). Mice were housed in a 12 h-12 h light-dark cycle and allowed ad libitum 
access to food and water. They received a regular chow diet. Mice were killed by 
cervical dislocation, and skeletal muscles were snap-frozen in liquid nitrogen 
and stored at −80 °C until RNA and protein isolation and histological stain-
ing. Rev-erb-α deficiency in mice was verified by qPCR analysis of skeletal 
muscle gene expression of Nr1d1and its known target gene Arntl, also known 
as Bmal1 (Supplementary Fig. 8a).
For Rev-erb-α overexpression, we cloned the coding sequence of Rev-erb-α 
in front of a muscle creatine kinase (MCK) promoter, allowing muscle-specific 
expression, and introduced a 1/2 adeno-associated virus (AAV) vector (Sirion 
Biotech, Germany). We injected 2.1 × 1010 infectious particles intramuscularly 
into the tibialis anterior muscle using the tibialis anterior muscle of the contra-
lateral limb as control. For pharmacological activation, SR9009 was administered 
intraperitoneally at 100 mpk for 30 d as previously described12. Control mice 
were injected with vehicle (15% cremophor in sterile water).
Maximal exercise stress test and endurance capacity. Two days before the 
experiment, mice were acclimatized to a single lane treadmill by performing 
a 10 m min−1 run. The day of the exercise stress test, mice were placed into 
the treadmill enclosed in a metabolic chamber connected to an oxygen sensor 
(Oxymax, Columbus Instruments, Columbus, Ohio). We measured basal oxygen 
consumption (VO2b) after a 30-min resting period; then, mice were encouraged 
to run on the treadmill at 10 m min−1 and 0% incline. Every 3 min, the tread-
mill speed was incremented by 4 m min−1 until the mice reached exhaustion 
to determine their maximal VO2 (VO2max). The speed at which VO2max was 
obtained was considered the maximal running speed (Vmax). One week later, we 
tested the mice for their endurance capacity. After a 6-min run at 30% of their 
maximal running speed, the treadmill speed was set at 70% of the VO2max. The 
experiment was stopped when mice stayed for 5 s continuously on the electrical 
grid. Time to exhaustion and total running distance were determined.
Daily wheel running activity. To record daily running wheel behavior, we 
placed the mice into individual cages containing running wheels for 3 weeks 
(Campden, Phymep, Paris). Wheel revolution was recorded daily during the 
last 2 weeks and averaged.
Training. We examined Rev-erb-α expression in control (untrained) and 
exercised mice. Mice were trained for 8 weeks, 5 d per week, 1–2 h per day at 
a starting speed of 8 m min−1, which was increased up to 16 m min−1 during 
the last 4 weeks.
Mouse care and use were performed according to approved institutional 
guidelines, and all experimental procedures were approved by the relevant ethic 
committees (Comité d’éthique en expérimentation animale Nord-Pas-De-Calais 
and The Scripps Research Institute Florida Campus Institutional Animal Care 
and Use Committee). We used male mice for all experiments.
Cell culture. We cultured C2C12 myoblasts in Dulbecco’s modified Eagle’s 
medium (DMEM; 4.5 g l−1 d-glucose; Gibco) supplemented with 10% FBS and 
1% gentamycin. Myogenic differentiation into myotubes was induced when cells 
reached 80% confluency by adding DMEM supplemented with 2% horse serum 
and 1% gentamycin at 37 °C in a humidified incubator under 5% CO2 for 2–5 d. 
As indicated in Figure 6, we added SR9009 or SR9011 (5 µM) to the medium 1 d 
before differentiation and for the length of the differentiation period (8 d).
Serum shock. We assessed circadian gene expression patterns in cells after 
synchronization by a 2-h horse serum shock on near-confluent cells39. After 2 h, 
the medium was changed to 2% serum-containing medium as above.
Retroviral production and infection. We cultured Phoenix Eco cells (Orbigen) 
in DMEM containing 10% FBS and 1% gentamycin at 37 °C under standard cul-
ture conditions. To generate cell lines constitutively overexpressing REV-ERB-α, 
we inserted the coding sequence of human NR1D1 in the pBabe retrovirus plas-
mid (Addgene) using the BamHI-SalII sites to generate pBabe–REV-ERB-α. We 
used the empty vector (pBabe) as control. To downregulate Nr1d1 expression, 
we inserted the Nr1d1 shRNA sequence in psilencer 5.1-U6 Retro (Ambion) 
using the BamH1 and HindIII sites. Phoenix cells (100,000 per cm2) were 
transfected with the pBabe plasmid constructs (20 µg) using the cationic lipid 
RPR 120535B as previously described40. C2C12 cells were infected with the 
supernatant from pBabe or pBabe–REV-ERB-α, and control (CTL) shRNA or 
Nr1d1 shRNA and puromycin-resistant infected cells were used within 15 d 
after infection. We verified NR1D1 overexpression by RT-qPCR on REV-ERB-α 
retrovirus–infected C2C12 cells compared to pBabe retrovirus–infected control 
cells (Supplementary Fig. 8b). We verified REV-ERB-α nuclear localization 
by western blot analysis (Supplementary Fig. 8c), and we verified its repres-
sive transcriptional activity by transient transfection on a consensus RevDR2 
site in C2C12 cells infected with REV-ERB-α retrovirus compared to those 
infected with pBabe retrovirus, as well as to noninfected C2C12 cells after 
transfection of a pSG5Rev-erb-α expression plasmid as control (Supplementary 
Fig. 8d). Nr1d1 downregulation was verified by qPCR analysis of Nr1d1 
mRNA on Nr1d1 shRNA–transduced C2C12 cells compared with control cells 
(Supplementary Fig. 8e).
Determination of cellular respiration. C2C12 cells (1 × 106 cells ml−1) sus-
pended in cell culture medium (RPMI + 10% FCS) were placed into the cham-
bers of the O2K oxygraph operating at 37 °C. Routine respiration was measured 
20 min later. Then, 2 µg ml−1 oligomycin was injected into the chambers to 
obtain the oligomycin-inhibited leak rate of respiration (4o, Leak, ‘L’), or uncou-
pled respiration. Finally, pulses of carbonyl cyanide-p-trifluoromethoxyphe-
nylhydrazone (FCCP) (1 µM) were added into the chambers until maximal 
oxygen consumption was reached (3u, OXPHOS, ‘P’). It represents the maximal 
respiratory capacity. The respiratory control ratio (RCR), or the coupled oxida-
tive phosphorylation, is expressed as 3u/4o ratio.
Oxygen consumption on permeabilized soleus fibers. After cervical disloca-
tion, soleus or tibialis anterior muscles were excised and placed into a Petri dish 
containing ice-cold biopsy preservation solution (BIOPS), and permeabilized 
fibers were prepared as previously described41. We placed fibers (3–6 mg wet 
weight) into the O2K oxygraph chambers (Oroboros Instruments, Innsbruck, 
Austria). In the first chamber, we added glutamate (10 mM) and malate (2 mM) 
to obtain state 2 respiration. Then, we injected 2.5 mM ADP into the chamber to 
measure ADP-coupled oxygen consumption (state 3). Further addition of suc-
cinate (10 mM) allowed estimation of the entire OXPHOS capacity. Finally, com-
plex I and complex III were inhibited with rotenone (0.5 µM) and antimycin A 
(2.5 µM), respectively. In the second chamber, we added palmitoyl-carnitine 
(5 or 20 µM) and malate (2 mM). After stabilization, coupled respiration was 
obtained with 2.5 mM ADP. Addition of exogenous cytochrome c (10 µM) was 
done in all experiments to test external membrane integrity. Experiments were 
performed at 25 °C.
Muscle mitochondria isolation. We cut muscles into small pieces and placed 
them into a trypsin-EDTA solution for 15 min at 4 °C. Samples were rinsed 
with mitochondrial isolation buffer (in mM: sucrose 300, TES 5, EGTA 0.2; 
pH 7.2) and homogenized with a glass tissue grinder. After centrifugation at 
800 g for 7 min, supernatant was collected and spun twice at 8,800g. The final 
mitochondrial pellet was suspended into respiration medium Mitomed2 and 
mitochondria (150 µg) were placed into the oxygraph chambers. Substrates and 
protocols were as described for permeabilized fiber respiration.
Mitochondria quantity and function. Quantification of mtDNA copy number. 
We isolated mitochondrial DNA (mtDNA) from mouse muscles after diges-
tion with Proteinase K (100 µg ml−1) by phenol/chloroform extraction. Relative 
amounts of nuclear DNA and mtDNA were determined by quantitative real-time 
PCR. We selected NADH dehydrogenase 1–coding gene for quantification of 
mtDNA and Ppia (also known as cyclophilin) for nuclear DNA quantification.
MitoTracker-FACS quantification. REV-ERB-α–overexpressing, Nr1d1 
shRNA–transduced cells and their respective control cells were washed with PBS, 
trypsinized and incubated at 37 °C for 20 min with 100 nM MitoTracker Green 
FM and Red FM dyes (Molecular Probes). MitoTracker Green probe preferen-
tially accumulates in mitochondria, allowing estimation of mitochondrial quan-





























in living cells and its accumulation is dependent on the membrane potential 
(Molecular Probes). Samples were washed 3 times in PBS and subjected to 
flow cytometric analysis on a FACSCalibur apparatus (Becton Dickinson, 
San Jose, California).
ATP assay. We measured ATP concentrations using a commercially available 
kit (EnzyLight ATP Assay Kit, Bioassay Systems, Hayward, California, USA) 
following the manufacturer’s instructions.
NAD assay. We measured NAD+ and NADH concentrations using a commer-
cially available kit (Biovision Research Products, Mountain View, California, 
USA) following the manufacturer’s instructions.
Quantitative PCR. We isolated total RNA from tissues by guanidinium 
thiocyanate/phenol/chloroform extraction42 and from C2C12 cells using the 
Trizol reagent (Invitrogen). Isolated RNA was reverse transcribed into cDNA 
using commercially available reagents (Superscript II kit, Applied Bioscience). 
We performed quantitative PCR (qPCR) with the Brilliant III SYBR Green QPCR 
Master Mix (Agilent) and specific primers following manufacturer’s instructions 
and using a Mx3005 apparatus (Agilent). Gene expression was normalized to 
cyclophilin and expressed as indicated in the legends to figures. A list of specific 
primers is available in Supplementary Table 1.
Antibodies and immunoblotting. Proteins extracted from muscle biopsies or 
cells were separated by SDS-PAGE and we performed immunoblot analyses 
according to standard procedures. Proteins were transferred onto PVDF mem-
branes and immunoblot analyses were carried out using antibodies directed 
against p-AMPK (Thr172) (1:1,000, Cell Signaling Technology 2535) and 
AMPK (1:1,000, Cell Signaling Technology 2532), Ppargc-1α (1:500, Santa-Cruz 
Biotechnology, sc-13067), Gapdh (1:500, Santa-Cruz Biotechnology, sc-25778), 
actin (1:1,000, Santa-Cruz Biotechnology sc-1616), Bnip3 and Map1lc3a (1:1,000, 
Abcam38621 and Abcam51520, respectively), Park2 (1:1,000, Millipore ab9244), 
Acac (1:1,000, Cell Signaling 3662), p-Acac (S79) (1:1,000, Cell Signaling 3661), 
OXPHOS (1:1,000, MitoSciences InVitrogen, iv 458099), Rev-erb-α (1:1,000, 
Perseus Proteomix PP-A8740A-00) following the manufacturer’s instructions.
Ppargc-1a acetylation assay. We analyzed Ppargc-1α acetylation in quad-
riceps muscle by immunoprecipitation of Ppargc1-α from 500 µg of protein 
extract with antibodies to Ppargc-1α (Santa Cruz, sc-13067, 2 µg per sample) 
followed by western blot analysis using antibodies to acetyl-lysine (1:2,000, Cell 
Signaling 9441).
Electron microscopy analysis of muscle sections. We examined ultrastruc-
tural muscle morphology using transmission electron microscopy. To this end, 
muscle tissue blocks were fixed in 2.5% glutaraldehyde in 0.1 M phosphate buffer 
(pH 7.4). Post-fixation was performed in 1% OsO4 in 0.1 M cacodylate buffer 
(pH 7.4) supplemented with 1.5% K4[Fe(CN)6]. Subsequently, samples were 
dehydrated and embedded in epon. Ultrathin sections were examined using a 
Philips CM100 electron microscope.
Immunofluorescence assay. Frozen cross-sections of muscle were fixed with 
acetone and incubated with antibodies directed to CD31 (1:100, BD Biosciences, 
BD557355), Pax7 (1:20, Developmental Studies Hybridoma Bank, PAX7), fiber 
types (1:25, Developmental Studies Hybridoma Bank, A4.840), and laminin 
(1:50, Sigma L9393). After incubation with the appropriate fluorescent-labeled 
secondary antibodies (goat anti-rabbit IgG conjugated to AlexaFluor 555 for 
CD31, goat anti-mouse IgG1 conjugated to AlexaFluor 488 for Pax7, goat anti-
rabbit IgG conjugated to AlexaFluor 350 for laminin and goat anti-mouse IgM 
conjugated to AlexaFluor 488 for A4.840, all from InVitrogen/Molecular Probes) 
and DAPI (30 nM, Invitrogen) for nuclei, sections were mounted in Mowiol. 
Images were captured with a Nikon E800 fluorescence microscope43.
Flow cytometry Map1lc3a analysis. REV-ERB-α–overexpressing and control 
cells were seeded in 6-well plates and serum-starved in presence or absence of 
Bafilomycin (50 nM) or NH4Cl (25 mM) overnight at 37 °C.
Before staining with antibody to Map1lc3a (1:50, MBL International M152-3 
clone 4E12), we fixed the cells with 4% paraformaldehyde for 15 min at room 
temperature, washed them in PBS and then permeabilized them with digitonin 
(100 µg ml−1) for 15 min at room temperature. Digitonin permeabilization 
allowed the extraction of the cytosolic form of Map1lc3a protein (Map1lc3a-I) 
and the specific detection of the lipidated Map1lc3a–membrane-associated frac-
tion (Map1lc3a-II), which correlates with the number of autophagosomes44. 
Cells were finally incubated with Alexa Fluor 488–conjugated antibody to mouse 
IgG for 15 min (1:200, Invitrogen, A11001). We acquired sample signals using 
FACSCalibur (Becton Dickinson, San Jose, CA) and analyzed them using FlowJo 
software (Tree Star).
Chromatin immunoprecipitation. We performed ChIP-qPCR experiments as 
previously described45 with minor changes as follows. Differentiated C2C12 
cells infected with the REV-ERB-α or control (pBabe) retrovirus were cross-
linked in 1% formaldehyde for 10 min at room temperature. Nuclear extracts 
were prepared, and the chromatin was sonicated for 15 min using the Bioruptor 
(Diagenode). Chromatins were immunoprecipitated overnight at 4 °C with anti-
bodies to Rev-erb-α (Cell Signaling Technology, 2124), H3K9Ac (Millipore, 
17-658) or H3K27Ac (AbCam, ab4729), all at 3 µg per sample, and then incu-
bated for 4 h at 4 °C with protein A and protein G Dynal magnetic beads (Dynal 
Biotech, Norway) and tRNA (10 µg ml−1). Cross-linking was reversed overnight 
at 65 °C. DNA was purified using the QIAquick PCR purification kit (Qiagen) 
and was analyzed by quantitative PCR using the Brilliant III SYBR Green QPCR 
Master Mix (Agilent) using specific primers (Supplementary Table 2).
Statistical analyses. Values are means ± s.e.m. of the indicated number of mea-
surements. Statistical significance was determined using two-tailed unpaired 
Student’s t-test with a significance of 0.05 or log-rank Mantel-Cox test.
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